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N-Glycosylation
The present invention relates to a mammalian cell comprising a gene encoding a polypeptide of interest, wherein the
polypeptide of interest is expressed comprising one or more posttranslational modification patterns. These modifications
are useful for example in glycoprotein production where the antibodies with the modifications have an enhanced antibody-
dependent cell-mediated cytotoxicity (ADCC). The present invention also relates to methods for producing the
glycoproteins and compositions comprising the glycoproteins, and their uses.
 
General information
State: Published
Organisations: Novo Nordisk Foundation Center for Biosustainability, Glyco-Engineering of CHO
Authors: Clausen, H. (Intern), Yang, Z. (Ekstern), Fevzi Halim, A. (Ekstern), Bennett, E. (Ekstern), Behrens, C. (Ekstern),
Vester-Christensen, M. B. (Ekstern), Herbert Rahmann, S. (Ekstern)
Publication date: 16 Jun 2016
 
Publication information
Country: International Bureau of the World Intellectual Property Organization (WIPO)
IPC: C12P 21/ 00 A I
Patent number: WO2016091268
Date: 16/06/2016
Priority date: 16/07/2015
Priority number: US201562193403P
Original language: English
Electronic versions: 
WO2016091268A2.pdf 
Main Research Area: Technical/natural sciences
Source: espacenet
Source-ID: WO2016091268
Publication: Research › Patent – Annual report year: 2016
 
